ANALYST-UPGRADE filed
HSBC upgraded the stock from Hold to Buy with a $95 price target, a 90% increase from its prior $50 target, citing accelerating earnings momentum and institutional accumulation. The firm has a 55% accuracy rate (145/263 calls), below top-tier peers like Morgan Stanley (80%) and Mizuho (57%). Consensus remains cautious: 28% Buy-rated (13 of 41 analysts), with a $52.26 mean target. Recent EPS revisions are sharply positive, 8 upward revisions in 30 days for +1y estimates. Earnings due in two days. Institutional buying surged, including a new $2.2B position from Norges Bank. Short interest remains elevated at 42.1% of float. This contrarian double upgrade from a mid-tier firm ahead of earnings amplifies signal strength despite consensus divergence.